1. Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis. Issue 1 (4th June 2022) Authors: Dimopoulos, Meletios A.; Moreau, Philippe; Augustson, Bradley; Castro, Nelson; Pika, Tomas; Delimpasi, Sosana; De la Rubia, Javier; Maiolino, Angelo; Reiman, Tony; Martinez‐Lopez, Joaquin; Martin, Thomas; Mikhael, Joseph; Yong, Kwee; Risse, Marie‐Laure; Asset, Gaelle; Marion, Sylvia; Hajek, Roman Journal: American journal of hematology Issue: Volume 98:Issue 1(2023) Page Start: E15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients—An analysis from the Brazilian Hodgkin Lymphoma Registry. Issue 5 (26th October 2017) Authors: Biasoli, Irene; Castro, Nelson; Delamain, Marcia; Silveira, Talita; Farley, James; Pinto Simões, Belinda; Solza, Cristiana; Praxedes, Monica; Baiocchi, Otávio; Gaiolla, Rafael; Franceschi, Fernanda; Bonamin Sola, Caroline; Boquimpani, Carla; Clementino, Nelma; Fleury Perini, Guilherme; Pagnano, K... Journal: International journal of cancer Issue: Volume 142:Issue 5(2018) Page Start: 883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. Issue 8 (August 2017) Authors: Jurczak, Wojciech; Moreira, Ilídia; Kanakasetty, Govind Babu; Munhoz, Eduardo; Echeveste, Maria Asunción; Giri, Pratyush; Castro, Nelson; Pereira, Juliana; Akria, Luiza; Alexeev, Sergey; Osmanov, Eugeniy; Zhu, Peijuan; Alexandrova, Siyka; Zubel, Angela; Harlin, Olof; Amersdorffer, Jutta Journal: Lancet Issue: Volume 4:Issue 8(2017) Page Start: e350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry. Issue 1 (23rd June 2017) Authors: Biasoli, Irene; Castro, Nelson; Delamain, Marcia; Silveira, Talita; Farley, James; Simões, Belinda Pinto; Solza, Cristiana; Praxedes, Monica; Baiocchi, Otávio; Gaiolla, Rafael; Franceschi, Fernanda; Sola, Caroline Bonamin; Boquimpani, Carla; Clementino, Nelma; Perini, Guilherme; Pagnano, Kátia; S... Journal: Hematological oncology Issue: Volume 36:Issue 1(2018) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗